-
The OneHealthdrugs COST Action network brings together experts to advance the discovery of innovative drugs and therapeutic targets aimed at combating vector-borne infections in both human and veterinary medicine. By adhering to the principles of an optimal drug profile, our approach enhances treatment effectiveness while minimizing environmental impact.
Don't miss this opportunity to connect, collaborate, and contribute to cutting-edge research in the fight against infectious diseases!
Industry stakeholders and the academia/industry interface - Considerations, roadmap and assays for target and off-target effects
- Targets for VBDs: identification and structural characterization
- Unintended side effects of pharmaceuticals on the ecosystem level
- Promising synthetic and natural compounds against VBDs
- Workshop: Young innovators and career development
Keynote speaker:
Thomas Geurden (Zoetis, Belgium)
Invited speakers:
Alvaro Baeza Garcia (UAntwerp, Belgium)
Tomas Brodin (SLU Umea, Sweden)
Johannes Charlier (EU-COST ENVIRANT, Kreavet, Belgium)
Yann Sterckx (UAntwerp, Belgium)
Ana Isabel Olías Molero (AEMPS, Spain)
Benoit Stijlemans (VUB, Belgium)
Maarten Vanhove (Uhasselt, Belgium)
Onehealtdrugs speakers:
Mirco Bundschuh (RPTU, Germany)
Guy Caljon (UAntwerp, Belgium)
Maria Paola Costi (Modena, Italy)
Elisabeth Davioud-Charvet (CNRS Strasbourg, France)
Sheraz Gul (Fraunhofer, Germany)
Cecilia Pozzi (Siena, Italy)
Joana Tavares (i3S, Portugal)
Serge Van Calenbergh (UGent, Belgium)
